Polyoma small T antigen (PyST), an early gene product of the polyoma virus, has been shown to cause cell death in a number of mammalian cells in a protein phosphatase 2A (PP2A)-dependent manner. In the current study, using a cell line featuring regulated expression of PyST, we found that PyST arrests cells in mitosis. Live-cell and immunofluorescence studies showed that the majority of the PyST expressing cells were arrested in prometaphase with almost no cells progressing beyond metaphase. These cells exhibited defects in chromosomal congression, sister chromatid cohesion and spindle positioning, thereby resulting in the activation of the spindle assembly checkpoint. Prolonged mitotic arrest then led to cell death via mitotic catastrophe. Cell cycle inhibitors that block cells in G1/S prevented PyST-induced death. PyST-induced cell death that occurs during M is not dependent on p53 status. These data suggested, and our results confirmed, that PP2A inhibition could be used to preferentially kill cancer cells with p53 mutations that proliferate normally in the presence of cell cycle inhibitors.
INTRODUCTION
Murine polyoma virus, a small DNA tumor virus, encodes three early gene products: large T (PyLT), middle T (PyMT) and small T (PyST) (see Cheng et al. 1 for a comprehensive review). Studies on polyoma viruses have long focused on the host cell proteins that are bound by the various early gene products. Thus, p53 and pRb were either first recognized or first studied via their interactions with SV40 large T, 2,3 whereas PI3 kinase was first studied via its interaction with PyMT. 4 A key binding protein for PyST is the protein phosphatase 2A (PP2A). 5 Previous work from our laboratory and others has shown that much of the functionality of both PyST and SV40 ST (SVST) is dependent on their ability to bind to PP2A. 5, 6 PP2A is a serine-threonine phosphatase that has been implicated in the regulation of multiple signaling pathways regulating tumor suppression, mitosis and cell death. [7] [8] [9] [10] [11] Majority of the PP2A complexes exist as heterotrimeric complexes composed of a scaffolding A subunit (Aα or Aβ), a catalytic C subunit (Cα or Cβ) and a regulatory B subunit. However, a smaller fraction can exist as dimeric complexes (reviewed in Sents et al. 12 ). As there are multiple families of B subunits (B, B′, B′′ or B′′′ family members), PP2A can exist as more than 80 different complexes. 8, 13 ST antigens bind to PP2A-A subunits and replace B subunits in the enzyme complex, thereby modulating PP2A function. PyST can bind either PP2A-Aα or Aβ, whereas SVST antigen can only bind PP2A-Aα. 14, 15 Previously, we showed that PyST can either induce or prevent apoptosis depending on what other signals the cell is receiving. 15, 16 Under normal growth conditions in the presence of serum, we found that expression of PyST via retroviral infection induces apoptosis in murine fibroblasts. 16 Notably, SVST expressed via the same vector fails to cause apoptosis under the same conditions. 16 We went on to demonstrate that there are other major differences between SVST and PyST in their effects on differentiation, transformation and cell survival. 15 However, PyST expression decreased with cell passaging (due to death-associated cell dropout), thereby hindering our efforts to characterize PyST-mediated cell death. 16 In this report, we describe the engineering of a cell line featuring regulated expression of PyST and show that PySTmediated cell death occurs during cell division, and that p53 is dispensable for this process. PyST expression triggers chromosome alignment defects. The spindle assembly checkpoint (SAC) cannot be satisfied, arresting cells at, or before, metaphase. Prolonged mitotic arrest leads to mitotic catastrophe-associated cell death. Arresting cells before cell division protects them from PyST-mediated cell death. Harnessing this data, we show that PP2A inhibition can be used to selectively kill cancer cells that are resistant to cell cycle arrest such as those with deregulated p53 function.
RESULTS

PyST triggers mitotic arrest
Constitutive PyST expression is toxic to cells and PyST levels decreases with cell passaging, thereby complicating further characterization of PyST-induced cell death. 16 To overcome this, we constructed a U2OS osteosarcoma cell line in which PyST expression is under the control of a tetracycline-regulated promoter system in order to allow regulated protein expression. Western blotting revealed that protein expression was tightly regulated, and high levels of PyST expression were observed upon doxycycline treatment (Supplementary Figure 1A ). In addition, using immunofluorescence, we observed that PyST was found in the cytoplasm and in the nucleus, as has been seen in previous studies 17 (Supplementary Figure 1A -ii).
Notably, there was an increase in the proportion of round, refractile cells following PyST expression, a phenotype associated with mitotic cells. This change was observable after 8 h of protein expression and peaked at about 30 h (Figure 1a-i), suggesting that PyST expressing cells may be arrested in mitosis. After 30 h of PyST expression, we fixed and stained PyST expressing and control U2OS cells with propidium iodide and analyzed samples with flow cytometry. DNA content analysis revealed that 460% of the PyST expressing cells were in the G2 or M phases, compared with o15% for the control cells (Figure 1a -ii). Treating cells with okadaic acid (OA), a well-known PP2A inhibitor, elicited similar results, as has been reported in the literature (Zheng et al. 18 and data not shown). Immunofluorescence micrographs of mitotic markers such as phosphohistone H3 and cyclin B (Figure 1b-i) showed that a majority of the PyST expressing cells were in the mitotic phase of the cell cycle. Similarly, western blotting demonstrated that PyST expressing cells had higher levels of late G2 to M cell cycle markers such as phosphorylated aurora kinase (AUK) and phosphorylated polo-like kinase1 (Figure 1c ). Similar results were obtained with murine NIH 3T3 cells (Supplementary Figure 2 ).
PyST expressing cells are blocked before chromosome congression
We sought to determine at which stage in mitosis the PyST expressing cells were arrested. To this end, we expressed histone H2B-GFP in the inducible PyST expressing cells and performed time-lapse imaging experiments in both the uninduced and PyST expressing conditions. Uninduced cells progressed normally through the cell cycle, with cells spending on average between 30-60 min in mitosis, as observed by chromosome condensation and nuclear breakdown, followed by alignment of the chromosomes at the metaphase plate, segregation of the chromosomes to the poles in anaphase and, finally, cytokinesis (Figure 2a and Supplementary Movie 1). In contrast, the majority of the PyST expressing cells did not progress beyond metaphase. PyST expressing cells were blocked in mitosis for prolonged periods . PyST expressing cells failed to align their chromosomes at the metaphase plate. Even in cases where most of the chromosomes seemed to be aligned at the metaphase midplate, after a brief metaphase arrest, cells scattered their chromosomes and regressed to a prometaphase-like state, with their chromosomes tumbling along the mitotic spindle (Figure 2c and Supplementary Movie 3). OA treatment also triggered a similar prometaphase-like mitotic arrest, with cells tumbling along the spindle axis ( Supplementary Figure 3 and Supplementary Movie 4). In an alternative approach to obtain high-resolution data, we fixed control cells and cells expressing PyST and stained them with 4 0 ,6-diamidino-2-phenylindole (DAPI) and pan phospho-AUK. The persistence of pan phospho-AUK staining in PyST expressing cells confirmed that these cells were still in mitosis ( Figure 3a ). Control cells displayed a normal cell cycle distribution with the majority of the cells in interphase. Control mitotic cells showed roughly equal proportions of mitotic cells in prometaphase (~34%), metaphase (~34%), and anaphase and telophase combined (32%; Figure 3b ). However, a majority of the PyST expressing cells were in mitosis, predominantly arrested in a prometaphase-like state (~90%; Figure 3b -ii). Moreover, only a small proportion of these cells were observed to have their chromosomes aligned at the metaphase plate (~10%) and almost no cells were seen in anaphase ( Figure 3b ). PyST expressing cells exhibit aberrant spindle formation, premature chromatid separation and spindle checkpoint activation We next used αand γ-tubulin immunostaining to assess the status of the mitotic spindles. There was an increase in the incidence of multipolar spindle formation in PyST expressing cells (30% in PyST expressing cells compared with 3% in control cells) that correlated with the failure of chromosome alignment, whereas control cells had normal bipolar spindles ( Figure 4a ). In general, the spindle axis is thought to lie parallel to the substratum (reviewed in Toyoshima and Nishida 19 ). However, we observed that PyST expressing cells frequently contained misaligned spindle axes. Images of γ-tubulin staining for different z-stacks (0.3 µm intervals) were obtained and the orientation of the mitotic spindle in relation to the coverslip was determined. Although we were able to observe both the spindle poles of the control cells on the same z-plane (or very close to each other), they were frequently represented in different z-planes for PyST expressing cells that had bipolar spindles. As PyST expressing cells contained misaligned chromosomes, we also asked whether they had lost their centromeric cohesion. We prepared mitotic chromosome spreads for control and PyST expressing U2OS cells, and co-stained with anti-centromere antibodies and Hoechst 33342 for DNA visualization. In control cells, only~5% of the cells had lost cohesion, whereas in PyST expressing cells~60% exhibited separated or completely scattered sister chromatids ( Supplementary Figure 4 and Figure 4c ).
Finally, we tested whether the SAC had been triggered. As expected for prometaphase arrested cells, PyST expressing cells contained higher levels of phosphorylated checkpoint proteins, Bub1 and BubR1, compared with control cells as detected by western blotting (Figure 5a ). PyST expressing cells also showed characteristic Bub1 and BubR1 staining associated with SAC activation at the kinetochores (Figure 5b ). 20, 21 Consistent with these data, SAC override, achieved by treating PyST expressing cells with an inhibitor of MPS-1, 22 a dual-specificity kinase required for proper functioning of the SAC, rescued cells from G2/M cell cycle arrest (although the cells died in subsequent cell division cycles; data not shown). These results reveal that PyST expressing cells are defective in their ability to align chromosomes at the metaphase plate, and that they possess aberrant mitotic spindles. Failure to align chromosomes on a normal biploar spindle and the resulting failure to satisfy the SAC in these cells leads to prolonged mitotic arrest.
PyST kills cells during cell division via mitotic catastrophe-mediated apoptosis
The mitotic arrest caused by expression of PyST for 30 h was followed by cell death. Flow cytometry (FACS) analysis at 40 h showed that 460% of the PyST expressing cells were in the sub-G1 cell population (compared with~3% for control cells (Figure 6a ). Similarly, apoptosis was elevated in PyST expressing cells as indicated by an increase in fragmented DNA (Figure 6b ). To further characterize cell death, and to confirm that PySTmediated cell death involved poly-ADP-ribose polymerase (PARP) activation, 16 we analyzed total PARP levels via western blotting in lysates harvested from control U2OS cells and U2OS cells expressing PyST. PyST expressing cells showed significantly higher levels of cleaved PARP compared with control cells, consistent with the induction of apoptosis ( Figure 6c ). To determine the mode of cell death, we performed live-cell imaging in PyST expressing cells. As noted earlier, a majority of the PyST expressing cells were arrested in mitosis. Prolonged attempts at chromosome alignment at the metaphase plate were not successful, and cells ultimately died while still being trapped in mitosis (Figure 6d and Supplementary Movie 5). These cells displayed characteristic apoptotic morphological features such as membrane blebbing, cell shrinkage and DNA condensation (Figure 6d and Supplementary Movie 5). There was no detectable exit from mitosis. Notably, the apoptotic effects induced by PyST expression, could be negated by treating cells with aphidicolin, etoposide or hydroxyurea-molecules that inhibit DNA synthesis and arrest cells in S phase (Figure 6e ). This is consistent with our observations that cell death occurs in mitosis.
As an independent test to confirm that PyST induces apoptosis in G2/M, we expressed a fusion protein in which PyST was fused at its COOH terminus to 'degrons', which resulted in its destruction at certain phases of the cell cycle (Sakaue-Sawano et al. 23 and Naetar et al., manuscript in press). After 50 h of PyST expression, cells were either fixed and stained with crystal violet or were analzyed by western blotting for PARP cleavage (Figure 6f ). Notably, PyST fused to a geminin degron, which caused its destabilization outside of the G2/M phases, triggered cell death in U2OS osteosarcoma cells, whereas a PyST fused to a cdt1 degron, which caused its destruction outside of the G1 phase, was unable to kill ( Figure 6f ). Taken together, the data indicate that Figure 3 . A Majority of the PyST expressing cells were observed to be in the prometaphase stage. (a-i, ii) Phospho aurora staining confirmed that the PyST expressing cells were in mitosis. Control (CON) cells or PyST expressing cells (24 h induction) were fixed and stained with anti-pan phospho-AUK (phospho-aurora A (Thr288)/ aurora B (Thr232)/aurora C (Thr198)), and tubulin antibodies followed by incubation with corresponding FITC/TRITC secondary antibodies. The phospho-aurora staining was found to be associated with the mitotic poles and the chromosomes in both the control and PyST cells. The cells were counterstained with DAPI. (b-i, ii) Control cells and PyST expressing cells analyzed with epifluorescence microscopy. The vast majority of the control cells were in interphase and a few cells were found to be in each of the other different mitotic states. In contrast, upon PyST expression, there was an increased prevalence of mitotic cells with PyST expression, and most of the cells were in a prometaphase-like state, with almost none of the cells in the later stages of mitosis. Results tabulated from counting mitotic cells in three such experiments are shown.
PyST-mediated cell death occurs via mitotic catastropheassociated apoptosis.
PyST-mediated cell death is independent of p53 status, and PP2A inhibition can be manipulated to preferentially kill p53-deregulated cancer cells As the U2OS cells we had been using express wild-type p53, we tested whether PyST-mediated cell death is p53 dependent. Both parental U2OS cells and isogenic U2OS cells expressing a dominant-negative allele of p53 (ddp53) were sensitive to PySTmediated cell death, indicating that p53 is dispensable for this process (Figure 7a ). Human H1299 cells, which are p53 null, were also sensitive to PyST-induced cell death (Figure 7a ). Although PP2A inhibitors such as OA have been considered as potential antitumor therapeutics, they are lethal to both tumor cells and normal cells alike. This is also true for PyST that kills both tumor cells and non-neoplastic cells such as HMEC and NIH 3T3. However, as shown above, cells are protected from PySTinduced cell death, when they are arrested by cell cycle inhibitors or DNA damaging agents shown to trigger cell cycle arrest in wildtype p53 cells. 24 As death mediated by PP2A inhibition did not require p53, we explored the possibility of selectively killing p53 null tumor cells while relying on the p53 in wild-type host cells to spare them via p53-mediated growth arrest. 25 To this end, we tested whether treatment of cells with a DNA damaging drug, such as etoposide, would arrest cells that synthesize and activate wild-type p53 and spare them from a PP2A inhibitor, while allowing p53 null cells to die.
Wild-type p53 U2OS cells and U2OS cells expressing dominantnegative p53 (ddp53) were seeded at low density and cultured till they reached about 60-80% confluence (~3 days) in the presence of a low dose of etoposide (150 nM). Etoposide treatment slowed the proliferation rate of wild-type U2OS cells, eventually forcing them into cell cycle arrest, whereas the cells expressing ddp53 were not affected. Following this treatment, the cells were treated with 15 nM OA for 48 h in the presence of etoposide. OA acid treatment triggered mitotic arrest and subsequent cell death in cells expressing ddp53 compared with the p53 wild-type cells that were arrested by etoposide treatment (Figure 7b ). Cells were then allowed to recover and cell density was measured via crystal violet staining (Figure 7b ). OA treatment killed~75% of the ddp53 expressing cells compared with~20% of normal cells (Figure 7b -ii). We also performed similar experiments in MCF10 A cells, a nontumorigenic human epithelial cell line, to determine whether similar results were obtained with other chemical inhibitors. 
MCF10 A cells and MCF10
A cells expressing ddp53 were treated with 200 nM aphidicolin for 4-5 days and then treated with 1.5 μM cantharidin-a PP2A inhibitor-for 18-20 h. Cells were then allowed to recover and cell density was measured via crystal violet staining (Figures 7c and d) . Cantharidin treatment killed 50% of the ddp53 expressing MCF10 A cells compared with 7% of normal cells when coupled with aphidicolin treatment (Figure 7c ).
DISCUSSION
Polyoma and SV40 T antigens have long been associated with tumorigenesis, usually driving cell cycle progression via their interactions with host cell proteins. Various combinations of T antigens along with activated oncogenes have regularly featured in the recipes for engineering tumor cells from primary cells (reviewed in Cheng et al. 1 
and Schaffhausen and Roberts 26 ).
Here we show that PyST, rather than driving cell cycle progression, instead mediates cell death during mitosis, and that p53 is dispensable for this process. PyST expressing cells fail to properly align their chromosomes at the metaphase plate, preventing progression to anaphase. Prolonged mitotic arrest leads to mitotic catastrophe-associated apoptosis. Notably, our studies of PySTassociated apoptosis have suggested a way to use PP2A inhibitors to kill p53 mutant tumor cells while sparing cells with normal p53.
Live-cell imaging of PyST expressing cells showed that cells that had reached partial metaphase alignments eventually reverted back to a prometaphase-like state, with their chromosomes tumbling along the mitotic spindle. There are a number of potential explanations for these results. One possibility is that the separation of sister chromatids observed when PyST is expressed (Figure 4 ) prevents chromosome bi-orientation and triggers prometaphase arrest. 27 This could be caused by an inappropriate release of cohesin that holds chromatids together. Indeed, PP2A along with shugoshin has a critical role in the protection of cohesion at centromeres during mitosis. [28] [29] [30] However, our results do not necessarily implicate PyST in affecting cohesion through PP2A and Sgo1 because cohesion fatigue as an indirect result of prolonged mitotic arrest could also underlie our observations. 27 In either case, loss of spindle pole integrity as a consequence of failed chromosome cohesion may also explain the increase in incidence of multipolar spindle formation. 31 Additional experiments are needed to test the direct effect of PyST on Sgo1 and cohesion.
There are other factors that could also contribute to the observed mitotic arrest. Kinetochore fibers, a subset of microtubules that orchestrate chromosome alignment during mitosis, require the activity of PP2A (B56-PP2A complex) for their stability. 32 Preliminary data suggest that a proportion of PyST expressing cells have thinner kinetochore fibers (data not shown). This could lead to unstable kinetochore microtubule attachment, thereby resulting in SAC activation and mitotic arrest. Defects in spindle positioning (Figure 4b ) might also lead to delays in mitotic progression. 33 ST has been observed to either augment or diminish PP2A activity. 15, [34] [35] [36] Interestingly, both inhibitors (such as OA) and activators (specifically FTY720) of PP2A have shown promise in killing particular tumor types. 37, 38 However, it seems reasonable to hypothesize that the mitotic arrest induced by PyST in the inducible cells that we have characterized results from its ability to inhibit PP2A. Notably, OA treatment has also been shown to trigger mitotic arrest (Zheng et al. 18 and presented here). Although we are confident that the effects we see with PyST and OA are mediated via PP2A inhibition (PP2A binding defective PyST mutant does not kill cells, 16 and PP2A-A-beta inhibition kills cells 39 ), contributions by other phosphatases cannot be completely ruled out. Interactions of ST with other phosphatases have not been tested and, OA and cantharidin can inhibit other phosphatases such as PP1, PP4 and PP5. 40, 41 We are in the process of deciphering which B subunit knockdown could mimic PySTmediated mitotic defects. The levels of PyST that we see expressed via regulated expression in the present report are much greater than those achieved via constitutive expression in our previous reports. 15, 16 This is likely a result of progressive elimination from the culture of dying cells resulting from stable expression of PyST at any but the lowest levels.
Indeed, there are a few differences in the modes of cell death mediated by constitutive low PyST expression levels compared with regulated high PyST expression levels. For example, we saw caspase activation associated with the cell death mediated by regulated PyST expression (data not shown) but not with the apoptosis brought about constitutive expression. 16 Thus, there could be multiple modes of PyST-mediated killing, based on the amount of PyST expressed. Interestingly, adenoviral overexpression of SVST also results in very high levels of expression, and has also been reported to trigger mitotic arrest in fibroblasts. 42 Notably, cell death mediated by high levels of SVST is also p53 Figure 5 . PyST expression triggers SAC activation. To determine the status of the spindle checkpoint, the phosphorylation patterns of Bub1 and BubR1 were analyzed by western blotting (a). PyST expressing cells had increased levels of slowly migrating phosphorylated Bub1 and BubR1, indicating that the SAC is active. Cells were also stained with anti-Bub1 (b-i) or anti-BubR1 (b-ii) followed by FITC/Alexa 488 secondary antibodies for epifluorescence micrographs. PyST expressing cells had Bub1/BubR1 staining associated with their kinetochores. Representative micrographs from one of two such experiments are shown. CON, control.
independent. 43 Recent studies from the Branton group demonstrated a similar phenotype with the overexpression of adenoviral E4orf4 protein, which is another viral protein known to inhibit PP2A function. 44, 45 However, these two viruses differ in their mode of action; E4orf4 binds to PP2A B subunits, 44 whereas both SVST and PyST replace B subunits. We hypothesize that high levels of each of these proteins function like a wrench in the gears of PP2A, inhibiting its function in an OA-like manner. Notably, lower levels of expression of SVST and/or E4orf4 did not lead to mitotic catastrophe or indeed to apoptosis. In contrast, even low levels of expression of PyST causes mitotic arrest and cell death (Supplementary Figure 5 ). In this case, PyST may be acting to selectively target PP2A to one or more mitotic targets. Indeed, when we performed affinity purification of PyST complexes, a number of mitotic proteins were selectively pulled down (unpublished observation). It is possible that the PyST-mediated block in mitosis is regulated by its ability to control phosphorylation of these and or other mitotic proteins, resulting in either their overphosphorylation at high levels of PyST expression or underphosphorylation at low levels of PyST expression. Currently, we are examining how these binding proteins contribute to the development of cellular features characteristic of PyST-mediated mitotic blockage.
We have been struck by how toxic both OA and PyST are to tumor cells. However, while this is good news in that few cells would likely survive either agent to become resistant, both agents are clearly toxic to normal cells. In the current study, we show that polyoma ST-mediated cell death is independent of p53 status. This result is consistent with the previous finding from the Fried laboratory that PyST can overcome a strong p53 block to PyMT transformation of REF52 cells. 46, 47 As p53 is not required for PySTor OA-mediated cell death, we were able to exploit this property to use OA and other less toxic PP2A inhibitors to preferentially kill p53-deregulated cancer cells. This same trick, using DNA damaging agents to instigate cell cycle arrest in normal cells has been used by others to increase the therapeutic window of other compounds that attack the cell cycle machinery to cause cell death in mitosis (reviewed in Blagosklonny and Darzynkiewicz, 25 Kawabe, 37 Blagosklonny 48 and Castedo et al. 49 ) and we have extended this to PP2A inhibition. We also propose that more specific PP2A inhibitors that target a single PP2A complex involved in mitosis, or a subset of PP2A complexes, such as those that only target PP2A-A-beta-specific complexes, are likely to be more effective in cancer therapy. Currently, we are in the process of identifying novel PP2A substrates that regulate mitosis, as these could serve as attractive therapeutic targets.
MATERIALS AND METHODS Materials
Anti α-tubulin, doxycycline, crystal violet and cantharidin were purchased from Sigma (St Louis, MO, USA). Anti γ-tubulin and phosphorylated pololike kinase1 (Plk1) antibodies were purchased from Biolegend (San Diego, CA, USA). Antibodies against pan phospho-AUK, HA, phospho histone3 (Ser 10) and cyclin B were purchased from Cell Signaling Technology (Danvers, MA, USA). Anti-BubR1 antibody was purchased from BD Biosciences (San Jose, CA, USA), and centromere autoantibodies were purchased from Immunovision (Springdale, AR, USA). Secondary fluorescein isothiocyanate (FITC) and tetramethylrhodamine (TRITC) antibodies were obtained from Jackson Immunoresearch Laboratories (West Grove, PA, USA). Secondary Alexa 488 and Alexa 568 were obtained from BD Biosciences. Aphidicolin, hydroxyurea, etoposide and OA were obtained from Calbiochem (Billerica, MA, USA). pTREX plasmid was a gift from Novartis Pharmaceuticals (Cambridge, MA, USA). PyST was cloned in the pTREX plasmid using Figure 7 . PyST-mediated cell death is independent of p53 status and PP2A inhibition could be used to selectively kill p53-deregulated cancer cells. p53 is dispensable in PyST-induced cell death. (a) Retroviral overexpression of PyST triggered cell death in H1299 cells (p53 null cell line), and in normal U2OS cells and U2OS cells engineered to overexpress dominant-negative p53 (ddp53). Cell density was assessed by crystal violet staining and the end of~4 days after retroviral transduction. (b) PP2A inhibition coupled with etoposide (ET) treatment can be used to preferentially kill p53-deregulated cells. U2OS and ddp53 expressing U2OS cells were treated with 150 nM etoposide for 3 days, following which 15 nM OA was supplemented to the medium for 48 h. The inhibitors were removed and cells were analyzed the following day. Cell density was assessed by crystal violet staining (b) and quantifications (crystal violet) for three independent experiments normalized to the cell density with etoposide-treated conditions were plotted in b-ii. (c) MCF10 A and ddp53 expressing MCF10 A cells were treated with 200 nM aphidicolin (Aph) for 4-5 days, following which 1.5 μM cantharidin (Cant) was supplemented to the medium for 18-20 h. The inhibitors were removed and cells were analyzed the following day. Cell density was assessed by crystal violet staining and quantifications (crystal violet) for four independent experiments normalized to the cell density with Aph-treated conditions were plotted in c. CON, control. standard molecular biology techniques. Dominant-negative p53 (pWZL-p53DD) was a gift from Dr Jean Zhao. ST-HA-FLAG was also cloned in pBABE-puro-IRES-GFP (obtained from Addgene, Cambridge, MA, USA, plasmid 14430). PyST-Cdt1 and Geminin degron constructs were cloned by swapping PyST for SVST in the MSCV-puro-SV40-Cdt1/Geminin plasmids generated in Dr David Livingston's laboratory. pRXTN 50 plasmid was a gift from Dr James Iglehart.
Cell culture, retroviral and lentiviral infections U2OS cells, U2OS ddp53 cells (dominant-negative p53), HeLa cells, NIH 3T3 cells and H1299 cells were grown in Dulbecco's modified Eagle's medium (DMEM) medium supplemented with 10% fetal bovine serum and antibiotics (penicillin and streptomycin) at 5% CO 2 . Viral infections were performed as described in Andrabi et al. 16 in a BSL2 tissue culture facility. MCF10 A cells were cultured in DMEM/F12 (1:1) with 0.5% fetal bovine serum, 10 ng/ml human epidermal growth factor (hEGF), 0.5 μg/ml hydrocortisone, 10 μg/ml insulin and 10 μg/ml cholera toxin.
Regulated expression of ST antigen
pTREX-PyST U2OS cells were obtained by standard lentiviral infection as described above. PyST was expressed as a fusion protein with tandem FLAG and hemagglutinin (HA) tags at its C terminus. ST expression was induced by the addition of doxycycline (0.1-1 μg/ml) to these cells.
Immunofluorescence and live-cell imaging
The cells were either fixed with 4% paraformaldehyde in phosphatebuffered saline (PBS) or with ice-cold methanol. Cells were washed with PBS and permeabilized with 0.3% Triton X-100 in PBS and blocked with blocking buffer (1 × PBS/5% normal goat serum/0.3% Triton X-100) for 1 h. Chromosome spreads were prepared and categorized as described. 51 For staining, cells were incubated overnight with the appropriate primary antibody at 4°C. Subsequently, cells were washed with PBS, and incubated with fluorescent antibody (1:10 000 for FITC/TRITC antibodies and 1:1000 for Alexa Fluor antibodies in blocking buffer) at room temperature for 1-2 h. Coverslips were washed 3 × with PBS and mounted on glass slides with DAPI or Hoechst 33342 containing mounting medium (Vectashield from Vector Laboratories, Burlingame, CA, USA) or Prolong Gold (Invitrogen, Green Island, NY, USA), and visualized using a Zeiss (Thornwood, NY, USA) or Nikon (Melville, NY, USA) TE2000-U epifluorescence microscope with appropriate filters.
For live-cell imaging, pTREX-PyST U2OS cells were infected with retroviruses generated with a GFP-tagged Histone 2B cDNA construct (a gift from Dr Jean Zhao's laboratory at Dana-Farber Cancer Institute). Stable cells were then cultured in 35 mm Mattek tissue culture glass dishes and imaged with the Zeiss epifluorescence microscope equipped with a heating chamber and incubator (37°C). CO 2 (5%) was fed via a humidifying chamber. Time-lapse imaging captured one image every 3 min. Movies were made at five frames per second using Zeiss Axiovision software (Zeiss).
Western blotting
For western blotting, equal number of cells were seeded in six-well dishes and the samples were extracted by directly boiling with 2 × Laemmli sample buffer. In certain cases, cells were lysed with 50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40 and protease inhibitors (Roche, Indianapolis, IN, USA, complete mini tablets) at 4°C for 30 min, followed by centrifugation at 14 000 r.p.m. at 4°C. Proteins were separated using SDS PAGE, and then transferred to 0.2 or 0.45 μM nitrocellulose membranes. The membranes were blocked either with 5% bovine serum albumin (BSA) or 5% milk in 1 × Tris-buffered saline with Tween-20 (TBST). Primary antibodies were incubated overnight at 4°C, washed three times with 1 × TBST and then incubated with Odyssey secondary antibodies (1:10 000) for 90 min at room temperature. The blots were subsequently washed twice with TBST and once with TBS, and developed with an Odyssey infrared scanner (Licor, Lincoln, NE, USA).
DNA laddering and cell cycle analysis by FACS
DNA isolation for chromosomal fragmentation was performed as described by Chen et al. 52 Cell cycle analysis was performed as described in Andrabi et al. 16 and data were analyzed by ModFit.
Crystal violet staining
Equal number of cells expressing either empty vector or PyST were plated in 6 cm culture dishes and allowed to grow for a 3-4 days, washed once with PBS and fixed with 100% ethanol for 15 min. Fixed cells were then stained with 0.1% crystal violet for 30 min. Alternatively, for experiments involving staining quantification, cells were fixed with 10% acetic acid +10% ethanol fix solution and then stained with 0.4% crystal violet in 20% ethanol solution. In either case, the staining solution was discarded and the plates were washed with distilled water and dried. The dye was extracted with 10% acetic acid solution and quantified using a microplate spectrophotometer at 595 nm.
